ir.mirumpharma.comMirum Pharmaceuticals, Inc. - Investor Relations
ir.mirumpharma.com Profile
Ir.mirumpharma.com is a subdomain of mirumpharma.com, which was created on 2018-03-13,making it 6 years ago.
Discover ir.mirumpharma.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.mirumpharma.com Information
| HomePage size: 91.339 KB |
| Page Load Time: 0.163841 Seconds |
| Website IP Address: 162.159.129.11 |
ir.mirumpharma.com Similar Website
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Walmart Investor Relations - Investor Relations |
| Alphabet Investor Relations - Investor Relations - Alphabet |
| Investor Relations | Jacobs - Investor Relations |
ir.mirumpharma.com PopUrls
| Investor FAQs https://ir.mirumpharma.com/resources/investor-faqs/ |
| Mirum-Pharmaceuticals-Announces-European-Medicines- ... https://ir.mirumpharma.com/node/7286/pdf |
| Mirum Pharmaceuticals, Inc. - Investor Relations https://ir.mirumpharma.com/overview/default.aspx |
| News & Events https://ir.mirumpharma.com/news-events/default.aspx |
| Stock Performance https://ir.mirumpharma.com/stock-info/default.aspx |
| Financial Information https://ir.mirumpharma.com/financials/Financial-Statements/default.aspx |
| Governance Documents https://ir.mirumpharma.com/governance/governance-documents/default.aspx |
| Committee Composition https://ir.mirumpharma.com/governance/committee-composition/default.aspx |
| Financials SEC Filings https://ir.mirumpharma.com/financials/sec-filings/default.aspx |
| News Releases https://ir.mirumpharma.com/news-events/News/default.aspx |
ir.mirumpharma.com Httpheader
| Date: Sun, 12 May 2024 18:11:10 GMT |
| Content-Type: text/html; charset=utf-8 |
| Content-Length: 80872 |
| Connection: keep-alive |
| CF-Ray: 882c5ea8bdd27c49-LAX |
| CF-Cache-Status: REVALIDATED |
| Accept-Ranges: bytes |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| ETag: 2597f0de7e374125604787ab8633eb5a |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: cloudflare |
ir.mirumpharma.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.cloudfront.net *.cloudflareinsights.com *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" http-equiv="Content-Security-Policy"/ |
| content="7PZC33CdqIbp0gWcZwGxHNtjuQpXcOTuQqGcQxSCY3k" name="google-site-verification"/ |
| content="L65wGAN3FCqD5QIU8IImcEPpOsGATvxWrOjMEg87IkA" name="google-site-verification"/ |
ir.mirumpharma.com Html To Plain Text
Overview News & Events News Releases Events & Presentations Financials Financial Information SEC Filings Stock Stock Performance Historical Price Lookup Investment Calculator Analyst Coverage Corporate Governance Governance Documents Management Team Board of Directors Committee Composition Resources Investor FAQs Contact Us Email Alerts Investor Relations Overview News & Events News Releases Events & Presentations Financials Financial Information SEC Filings Stock Stock Performance Historical Price Lookup Investment Calculator Analyst Coverage Corporate Governance Governance Documents Management Team Board of Directors Committee Composition Resources Investor FAQs Contact Us Email Alerts Who We Are We are committed to developing safe and effective therapies for people with rare liver diseases. Ultimately, we want to help patients and their families experience a brighter future. Learn MoreRecent events Featured presentation Press releases View all releases Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Mirum Pharma, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Mirum Pharma to send you the requested Investor Email Alert updates. * Required Your Email * Investor Alert Options Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & Presentations Unsubscribe Email Alert Sign Up Confirmation Investor Contacts Ian Clements, Ph.D.Andrew McKibben 650-667-4085 ir@mirumpharma.com Media Contact Erin Murphy 510-508-6521 media@mirumpharma.com Quick Links SEC Filings Investor FAQs Governance Documents Privacy Policy Terms of Use Contact Us CA TISCAD © Mirum Pharmaceuticals Inc. - All rights reserved Powered By Q4 Inc. 5.122.0.3 (opens in new...
ir.mirumpharma.com Whois
Domain Name: MIRUMPHARMA.COM Registry Domain ID: 2238569783_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-10T04:07:04Z Creation Date: 2018-03-13T17:41:10Z Registry Expiry Date: 2025-03-13T17:41:10Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS59.DOMAINCONTROL.COM Name Server: NS60.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T16:08:15Z <<<